DOI : 10.1055/s-00000017

Experimental and Clinical Endocrinology & Diabetes

Issue 10 · Volume 120 · November 2012 DOI: 10.1055/s-002-24017


16. Jahrestagung der Sektion Neuroendokrinologie der Deutschen Gesellschaft für Endokrinologie (DGE)
Köln, 30. November 2012



P3
P4
Faust, M; Åkerblad, AC; Buchfelder, M; Johannsson, G; Jonsson, P; Kann, P; Touraine, P; Koltowska Häggström, M: Growth hormone replacement in adults with severe growth hormone deficiency is effective even if baseline IGF-1 levels are in the normal range
P6
Hoffmann, A; Gebhardt, U; Sterkenburg, AS; Warmuth-Metz, M; Kortmann, RD; Falldum, A; Pietsch, T; Calaminus, G; Sörensen, N; Müller, HL: Initial hypothalamic involvement is the major risk factor for impaired prognosis and quality of life in childhood craniopharyngioma regardless of chosen treatment strategies – Results of KRANIOPHARYNGEOM 2000
P8
Hölsken, A; Stache, C; Fahlbusch, R; Buchfelder, M; Buslei, R: Immunohistochemical analysis of cancer stem cell markers CD44 and CD133 in craniopharyngiomas
P10
Lucia, K; Scalfi, C; Wu, Y; Monteserin Garcia, JL; Buchfelder, M; Kuhlen, D; Stalla, GK; Renner, U: Immunomodulation of angiogenic factor production in pituitary tumor cells under basal and hypoxia-mimicking conditions
P12
Raffel, N; Stache, C; Hölsken, A; Flitsch, J; Fahlbusch, R; Buchfelder, M; Buslei, R: Distinct expression of the histon methyltransferase EZH2 in β-catenin accumulating cells of adamantinomatous craniopharyngiomas
P15
Stache, C; Hölsken, A; Raffel, N; Schlaffer, S; Fahlbusch, R; Buchfelder, M; Blümcke, I; Buslei, R: Polycomb group repressive complex protein EZH2 regulates tight junction protein Claudin-1 in craniopharyngiomas
P17
P18
Theodoropoulou, M; Riebold, M; Monteserin Garcia, JL; Stalla, GK: Targeting the IGF-IR system in pituitary tumors in vitro: antiproliferative action & pitfalls
P19
P20
Topuzoglu, T; Gouni-Berthold, I; Blau, T; Brinker, G; Faust, M; Runge, M; Schubert, M; Zeitler, K; Krone, W: 39-jähriger Patient mit hepatischer und ossärer Metastasierung eines hormoninaktiven Hypophysenkarzinoms